LDLRAP1 and familial hyperaldosteronism: This study provides the first molecular evidence in Tunisia linking pathogenic variants in LDLR (c.1845+1G>A) and LDLRAP1 (c.161G>A; p.Gly54Asp) to familial hypercholesterolemia (FH).